A Post Marketing Surveillance to Evaluate the Safety of Desidustat for the Treatment of Anemia in Subjects With Chronic Kidney Disease (CKD).(Real World Evidence Study)

NCT05515367 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

1004

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Diseases
Anemia of Chronic Kidney Disease

Interventions

DRUG: Desidustat

Sponsor

Zydus Lifesciences Limited